BR0307801A - Processo para a fabricação de derivados de ácido mevalÈnico inibidores da hmg-coa reductase - Google Patents
Processo para a fabricação de derivados de ácido mevalÈnico inibidores da hmg-coa reductaseInfo
- Publication number
- BR0307801A BR0307801A BR0307801-9A BR0307801A BR0307801A BR 0307801 A BR0307801 A BR 0307801A BR 0307801 A BR0307801 A BR 0307801A BR 0307801 A BR0307801 A BR 0307801A
- Authority
- BR
- Brazil
- Prior art keywords
- manufacture
- hmg
- acid derivatives
- coa reductase
- reductase inhibitors
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title abstract 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 title abstract 2
- 229940096701 plain lipid modifying drug hmg coa reductase inhibitors Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/535—Organo-phosphoranes
- C07F9/5352—Phosphoranes containing the structure P=C-
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
- C07F15/004—Iridium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
- C07F15/0053—Ruthenium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0073—Rhodium compounds
- C07F15/008—Rhodium compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/06—Cobalt compounds
- C07F15/065—Cobalt compounds without a metal-carbon linkage
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
"PROCESSO PARA A FABRICAçãO DE DERIVADOS DE áCIDO MEVALÈNICO INIBIDORES DA HMG-COA REDUCTASE". A presente invenção refere-se a um processo para a fabricação de um composto de fórmula ou um sal, especialmente um sal farmaceuticamente aceitável com uma base, deste ou uma lactona deste em que o elemento ........ representa -CH~ 2~-CH~ 2~ ou -CH=CH- e R representa um radical cíclico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0204129.1A GB0204129D0 (en) | 2002-02-21 | 2002-02-21 | Process for the manufacture of organic compounds |
PCT/EP2003/001738 WO2003070717A1 (en) | 2002-02-21 | 2003-02-20 | Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0307801A true BR0307801A (pt) | 2004-12-21 |
Family
ID=9931523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0307801-9A BR0307801A (pt) | 2002-02-21 | 2003-02-20 | Processo para a fabricação de derivados de ácido mevalÈnico inibidores da hmg-coa reductase |
Country Status (18)
Country | Link |
---|---|
US (3) | US7208623B2 (pt) |
EP (1) | EP1478640A1 (pt) |
JP (1) | JP2005520818A (pt) |
KR (1) | KR100978970B1 (pt) |
CN (1) | CN1318412C (pt) |
AU (1) | AU2003218994B2 (pt) |
BR (1) | BR0307801A (pt) |
CA (1) | CA2473075A1 (pt) |
EC (1) | ECSP045234A (pt) |
GB (1) | GB0204129D0 (pt) |
IL (1) | IL163279A (pt) |
MX (1) | MXPA04008110A (pt) |
NO (1) | NO20043919L (pt) |
NZ (1) | NZ534394A (pt) |
PL (1) | PL370596A1 (pt) |
RU (1) | RU2335500C2 (pt) |
WO (1) | WO2003070717A1 (pt) |
ZA (1) | ZA200405436B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0204129D0 (en) | 2002-02-21 | 2002-04-10 | Novartis Ag | Process for the manufacture of organic compounds |
CA2785954A1 (en) | 2003-02-12 | 2004-08-26 | Nissan Chemical Industries, Ltd. | Crystalline forms of pitavastatin calcium |
GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
US20070179166A1 (en) * | 2003-12-24 | 2007-08-02 | Valerie Niddam-Hildesheim | Process for preparation of statins with high syn to anti ratio |
US7851624B2 (en) * | 2003-12-24 | 2010-12-14 | Teva Pharamaceutical Industries Ltd. | Triol form of rosuvastatin and synthesis of rosuvastatin |
EP1634870A1 (en) * | 2004-08-27 | 2006-03-15 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Process and intermediates for the selective synthesis of Fluvastatin |
WO2006035286A2 (en) * | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof |
US8354530B2 (en) | 2005-07-28 | 2013-01-15 | Lek Pharmaceuticals d. d | Process for the synthesis of rosuvastatin calcium |
SI2024341T1 (sl) | 2006-05-03 | 2016-04-29 | Msn Laboratories Private Limited | Novi postopek za statine in njihove farmacevtsko sprejemljive soli |
SI2086945T1 (sl) | 2006-10-09 | 2016-05-31 | Msn Laboratories Private Limited | Novi postopek za pripravo statinov in njihovih farmacevtsko sprejemljivih soli |
EP2079712A2 (en) * | 2006-10-31 | 2009-07-22 | Aurobindo Pharma Limited | An improved process for preparing rosuvastatin calcium |
AU2008212622B2 (en) * | 2007-02-08 | 2011-01-27 | Aurobindo Pharma Limited | An improved process for preparation of rosuvastatin calcium |
PL2172471T3 (pl) * | 2007-04-18 | 2013-08-30 | Teva Pharma | Sposób otrzymywania produktów pośrednich inhibitorów reduktazy HMG-CoA |
WO2009009152A1 (en) * | 2007-07-12 | 2009-01-15 | Teva Pharmaceutical Industries Ltd. | Rosuvastatin intermediates and their preparation |
KR101063146B1 (ko) * | 2008-11-10 | 2011-09-07 | 미래파인켐 주식회사 | 피타바스타틴 중간체의 제조방법 및 이를 이용한 피타바스타틴 헤미 칼슘염의 제조방법 |
US8487105B2 (en) | 2009-01-19 | 2013-07-16 | Msn Laboratories Limited | Process for preparing pitavastatin, intermediates and pharmaceuctically acceptable salts thereof |
US8987444B2 (en) | 2010-01-18 | 2015-03-24 | Msn Laboratories Private Limited | Process for the preparation of amide intermediates and their use thereof |
EP3178812A1 (en) * | 2010-11-12 | 2017-06-14 | Hetero Research Foundation | Novel polymorphs of pitavastatin calcium |
FR2970178B1 (fr) * | 2011-01-07 | 2014-06-20 | Liliane Therese Jacquot | Promedicaments pour une delivrance specifique au niveau du foie et une meilleure tolerance |
CN103058925B (zh) * | 2011-11-02 | 2015-09-02 | 石药集团中奇制药技术(石家庄)有限公司 | 一种匹伐他汀钙的制备方法 |
TWI516520B (zh) | 2014-10-31 | 2016-01-11 | 財團法人工業技術研究院 | 波長轉換聚合物、其製法及包含其之波長轉換裝置 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851427A (en) | 1985-10-25 | 1989-07-25 | Sandoz Pharm. Corp. | Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use |
CA1336714C (en) | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis |
FI94339C (fi) | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
ATE158579T1 (de) | 1992-07-02 | 1997-10-15 | Hoechst Ag | Verfahren zur herstellung von (3r,5s)6-hydroxy- 3,5-0-isopropyliden-3,5-dihydroxy-hexansäure- tert.-butylester |
CA2164685C (en) | 1994-12-07 | 2005-03-08 | Takeshi Ohkuma | Method for producing an alcohol |
US6184381B1 (en) | 1995-12-06 | 2001-02-06 | Japan Science & Technology Corp. | Process for preparing optically active compounds |
JP3159661B2 (ja) * | 1997-02-21 | 2001-04-23 | 科学技術振興事業団 | 光学活性アルコール類の製造方法 |
US6187961B1 (en) * | 1997-11-06 | 2001-02-13 | Roche Vitamins Inc. | Process for the preparation of trans-(R,R)-actinol |
JPH11322649A (ja) * | 1998-03-16 | 1999-11-24 | Mitsubishi Chemical Corp | 光学活性アルコールの製造方法 |
JPH11335385A (ja) * | 1998-05-20 | 1999-12-07 | Takasago Internatl Corp | 遷移金属錯体および該錯体を用いた光学活性アルコールの製造方法 |
JP2000212110A (ja) * | 1999-01-27 | 2000-08-02 | Mitsubishi Chemicals Corp | 光学活性α―アルキルベンジルアルコ―ル類の製造方法 |
JP3630002B2 (ja) * | 1999-03-03 | 2005-03-16 | 三菱化学株式会社 | 光学活性1,2−ジオール類の製造方法 |
JP2000327659A (ja) * | 1999-03-15 | 2000-11-28 | Mitsubishi Chemicals Corp | 光学活性ピリジルアルコール類の製造方法 |
US6211412B1 (en) * | 1999-03-29 | 2001-04-03 | The University Of Kansas | Synthesis of epothilones |
US6603015B2 (en) * | 1999-03-29 | 2003-08-05 | University Of Kansas | Synthesis of epothilones |
JP2001104795A (ja) * | 1999-10-13 | 2001-04-17 | Mitsubishi Chemicals Corp | ルテニウム触媒組成物 |
JP3720235B2 (ja) * | 2000-03-14 | 2005-11-24 | 高砂香料工業株式会社 | 光学活性ルテニウムホスフィン錯体の製造方法及び該錯体を用いた光学活性アルコールの製造方法 |
ES2225330T3 (es) * | 2000-03-22 | 2005-03-16 | Hoffmann La Roche | Compuesto de piperidina y piperacina para empleo en el tratamiento de alzheimer. |
US6743926B2 (en) * | 2000-05-26 | 2004-06-01 | Ciba Specialty Chemicals Corporation | Process for the preparation of indole derivatives and intermediates of the process |
DE60106928T2 (de) * | 2000-07-24 | 2005-03-10 | Chirotech Technology Ltd. | Rutheniumkomplexe und ihre verwendung zur asymmetrischen hydrierung |
GB0204129D0 (en) | 2002-02-21 | 2002-04-10 | Novartis Ag | Process for the manufacture of organic compounds |
-
2002
- 2002-02-21 GB GBGB0204129.1A patent/GB0204129D0/en not_active Ceased
-
2003
- 2003-02-20 CN CNB038042886A patent/CN1318412C/zh not_active Expired - Fee Related
- 2003-02-20 RU RU2004128256/04A patent/RU2335500C2/ru not_active IP Right Cessation
- 2003-02-20 NZ NZ534394A patent/NZ534394A/en not_active IP Right Cessation
- 2003-02-20 WO PCT/EP2003/001738 patent/WO2003070717A1/en active IP Right Grant
- 2003-02-20 AU AU2003218994A patent/AU2003218994B2/en not_active Ceased
- 2003-02-20 EP EP03714750A patent/EP1478640A1/en not_active Withdrawn
- 2003-02-20 PL PL03370596A patent/PL370596A1/xx not_active Application Discontinuation
- 2003-02-20 BR BR0307801-9A patent/BR0307801A/pt not_active IP Right Cessation
- 2003-02-20 KR KR1020047013033A patent/KR100978970B1/ko not_active IP Right Cessation
- 2003-02-20 US US10/504,655 patent/US7208623B2/en not_active Expired - Fee Related
- 2003-02-20 MX MXPA04008110A patent/MXPA04008110A/es active IP Right Grant
- 2003-02-20 JP JP2003569624A patent/JP2005520818A/ja active Pending
- 2003-02-20 CA CA002473075A patent/CA2473075A1/en not_active Abandoned
-
2004
- 2004-07-08 ZA ZA200405436A patent/ZA200405436B/en unknown
- 2004-07-29 IL IL163279A patent/IL163279A/en not_active IP Right Cessation
- 2004-08-16 EC EC2004005234A patent/ECSP045234A/es unknown
- 2004-09-20 NO NO20043919A patent/NO20043919L/no not_active Application Discontinuation
-
2007
- 2007-03-09 US US11/684,134 patent/US20070155970A1/en not_active Abandoned
-
2008
- 2008-07-23 US US12/220,259 patent/US20080312462A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003218994A1 (en) | 2003-09-09 |
ZA200405436B (en) | 2005-06-17 |
PL370596A1 (en) | 2005-05-30 |
EP1478640A1 (en) | 2004-11-24 |
US20070155970A1 (en) | 2007-07-05 |
CN1636004A (zh) | 2005-07-06 |
CN1318412C (zh) | 2007-05-30 |
US7208623B2 (en) | 2007-04-24 |
IL163279A (en) | 2010-06-30 |
CA2473075A1 (en) | 2003-08-23 |
ECSP045234A (es) | 2004-09-28 |
KR20040111360A (ko) | 2004-12-31 |
RU2004128256A (ru) | 2005-06-27 |
US20080312462A1 (en) | 2008-12-18 |
NO20043919L (no) | 2004-09-20 |
WO2003070717A1 (en) | 2003-08-28 |
RU2335500C2 (ru) | 2008-10-10 |
US20050159480A1 (en) | 2005-07-21 |
NZ534394A (en) | 2006-10-27 |
AU2003218994B2 (en) | 2007-08-09 |
MXPA04008110A (es) | 2004-11-26 |
JP2005520818A (ja) | 2005-07-14 |
GB0204129D0 (en) | 2002-04-10 |
KR100978970B1 (ko) | 2010-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0307801A (pt) | Processo para a fabricação de derivados de ácido mevalÈnico inibidores da hmg-coa reductase | |
BR0010555A (pt) | Inibidores de neuraminidases | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
MXPA03006248A (es) | Derivados de acido fumarico como inhibidores de nf-kappab. | |
EP1090908A3 (en) | Cyclobutane derivatives as inhibitors of protein farnesyltransferase | |
MXPA04007396A (es) | Proceso para la elaboracion de inhibidores de reductasa hmg-coa. | |
NO20080865L (no) | Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer | |
DE69830504D1 (de) | Antithrombotische mitteln | |
BR122016015715B8 (pt) | composições farmacêuticas de metilamida de ácido 4[4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenóxi)-piridina-2-carboxílico | |
AR051778A2 (es) | Derivados del acido dimetilaminocrotonico y procesos para supreparacion | |
ATE260255T1 (de) | 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate | |
PT848004E (pt) | Derivados pirrolidina tendo actividade inibidora da fosfolipase a2 | |
BR0210842A (pt) | Processo para a preparação de intermediários úteis na sìntese de derivados de estatina, especialmente derivados do ácido 7-amino 3,5-dihidróxi heptanóico, e intermediários dos mesmos | |
BRPI0408338A (pt) | piperidinas substituìdas como novos inibidores de mdm2-p53 | |
BRPI0416287A (pt) | compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou prevenção de enfermidades que são moduladas por inibidores de accß e sua utilização | |
WO2004080922A3 (en) | Substituted vitamin d analogues and their therapeutic uses | |
ATE268751T1 (de) | Biphenylamidin-derivate | |
BR0309753A (pt) | Processo para a preparação de derivados de 6-alquilideno penem | |
BRPI0414630A (pt) | derivados ciclohexìlicos substituìdos com aminoalquilamida | |
BR0311801A (pt) | Composição de imidazol, método para produção do mesmo, composição farmacêutica, embalagem comercial, método para a profilaxia ou tratamento de doenças, método para erradicar helicobacter pylori de um animal infectado com helicobacter pylori, e, uso de um composto | |
HUP0201083A2 (hu) | Új atorvastatinsók és az azokat tartalmazó gyógyszerkészítmények | |
AU2001272761A1 (en) | Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products | |
BR0215602A (pt) | ésteres de boronato | |
BR9909870A (pt) | Pirrolidinas como inibidores de neuraminidases | |
BR0308807A (pt) | Compostos tiazol-2-il-imina como inibidores de pde-7 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE A 9A ANUIDADE. |